• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物打印搏动性Fontan导管的多物理场模拟

Multiphysics Simulations of a Bioprinted Pulsatile Fontan Conduit.

作者信息

Hu Zinan, Herrmann Jessica E, Schwarz Erica L, Gerosa Fannie M, Emuna Nir, Humphrey Jay D, Feinberg Adam W, Hsia Tain-Yen, Skylar-Scott Mark A, Marsden Alison L

机构信息

Department of Mechanical Engineering, Stanford University, Stanford, CA 94305.

School of Medicine, Stanford University, Stanford, CA 94305.

出版信息

J Biomech Eng. 2025 Jul 1;147(7). doi: 10.1115/1.4068319.

DOI:10.1115/1.4068319
PMID:40172060
Abstract

For single ventricle congenital heart patients, Fontan surgery is the final stage in a series of palliative procedures, bypassing the heart to enable passive flow of de-oxygenated blood from the inferior vena cava (IVC) to the pulmonary arteries. This circulation leads to severely elevated central venous pressure, diminished cardiac output, and thus numerous sequelae and premature mortality. To address these issues, we propose a bioprinted pulsatile conduit to provide a secondary power source for the Fontan circulation. A multiphysics computational framework was developed to predict conduit performance and to guide design prior to printing. Physics components included electrophysiology, cardiomyocyte contractility, and fluid-structure interaction coupled to a closed-loop lumped parameter network representing Fontan physiology. A range of myocardial contractility was considered and simulated. The initial conduit design with adult ventricular cardiomyocyte contractility values coupled to a Purkinje network demonstrated potential to reduce liver (IVC) pressure from 16.4 to 9.3 mmHg and increase cardiac output by 29%. After systematically assessing the impacts of contraction duration, fiber direction, and valve placement on conduit performance, we identified a favorable design that successfully reduces liver pressure to 7.3 mmHg and increases cardiac output by 38%, almost normalizing adverse hemodynamics in the lower venous circulation. Valves at the input and output of the conduit are essential to achieve these satisfactory results; without valves, performance is compromised. However, a potential drawback of the design is the elevation of superior vena cava (SVC) pressure, which varies linearly with liver pressure reduction.

摘要

对于单心室先天性心脏病患者,Fontan手术是一系列姑息性手术的最后阶段,该手术绕过心脏,使来自下腔静脉(IVC)的脱氧血液能够被动流入肺动脉。这种循环会导致中心静脉压严重升高、心输出量减少,进而引发众多后遗症和过早死亡。为了解决这些问题,我们提出了一种生物打印的搏动性管道,为Fontan循环提供辅助动力源。我们开发了一个多物理场计算框架,用于预测管道性能并在打印前指导设计。物理组件包括电生理学、心肌细胞收缩性以及与代表Fontan生理学的闭环集总参数网络耦合的流固相互作用。我们考虑并模拟了一系列心肌收缩性。最初的管道设计将成人心室心肌细胞收缩性值与浦肯野网络耦合,显示出将肝脏(IVC)压力从16.4 mmHg降至9.3 mmHg并使心输出量增加29%的潜力。在系统评估收缩持续时间、纤维方向和瓣膜位置对管道性能的影响后,我们确定了一种有利的设计,该设计成功地将肝脏压力降至7.3 mmHg,并使心输出量增加38%,几乎使下腔静脉循环中的不良血流动力学恢复正常。管道输入和输出端的瓣膜对于取得这些满意结果至关重要;没有瓣膜,性能就会受到影响。然而,该设计的一个潜在缺点是上腔静脉(SVC)压力升高,它随肝脏压力降低呈线性变化。

相似文献

1
Multiphysics Simulations of a Bioprinted Pulsatile Fontan Conduit.生物打印搏动性Fontan导管的多物理场模拟
J Biomech Eng. 2025 Jul 1;147(7). doi: 10.1115/1.4068319.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.高血压和心血管疾病患者的血压治疗目标。
Cochrane Database Syst Rev. 2022 Nov 18;11(11):CD010315. doi: 10.1002/14651858.CD010315.pub5.
5
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
6
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.用于预防激光小梁成形术后眼压暂时升高的围手术期药物。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2.
7
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.预防性左西孟旦用于预防先天性心脏病手术患儿的低心排血量综合征及死亡率。
Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD011312. doi: 10.1002/14651858.CD011312.pub2.
8
Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.预防性使用左西孟旦预防先天性心脏病手术患儿的低心排血量综合征和死亡率。
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD011312. doi: 10.1002/14651858.CD011312.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis.正性肌力药物预防先天性心脏病患儿心脏手术低心排血量综合征和死亡率的效果:网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Nov 26;11(11):CD013707. doi: 10.1002/14651858.CD013707.pub2.